Coming soon
News
Optellum Awarded NIHR Funding for Multi-Site NHS Pilot Study for Accelerated Lung Cancer Diagnosis
Optellum announced it has been awarded funding for a competitive programme, Invention for Innovation (i4i), focused on transformative and disruptive innovations...
Read more

August 1, 2022 / Insights
How Optellum is working to change the survival rates for lung...Optellum was founded with the vision of providing clinical decision support software that could help lung disease patients be diagnosed and treated with curative...

June 30, 2022 / Events
Optellum welcomes ESTI back to Oxford for 2022 congressIn June 2022, the European Society of Thoracic Imaging (ESTI) held its first in-person annual scientific meeting since the pandemic. Optellum were fortunate to...

June 28, 2022 / Clinical & Regulatory
PRESS RELEASE: CMS assigns new technology payment classification for Optellum’s Lung...This payment assignment to a newly available Healthcare Common Procedure Coding System (HCPCS) code constitutes an important step towards reimbursing providers for the use...

June 16, 2022 / Clinical & Regulatory
Optellum’s UK regulatory certification bolstered by UKCA marking for its early...After gaining CE certification for its software Virtual Nodule Clinic, Optellum has attained UKCA certification under the UK’s Medical Devices Regulations. Optellum, an Oxford-based...

June 15, 2022 / Insights
The practical considerations of applying AI in healthcare settingsBy Dr Johnathan Watkins, VP of Market Access and Clinical Research, Optellum In September 2021, The National Artificial Intelligence (AI) Strategy was launched by...

June 6, 2022 / Events
Optellum is attending the 2022 ASCO Annual MeetingOptellum is attending the 2022 ASCO Annual Meeting in Chicago along with our partners from GE Healthcare. At this year’s ASCO 2022 annual meeting, GE Healthcare will...

May 28, 2022 / News & Press, Research & Publications
PRESS RELEASE: Researchers Use AI to Predict Cancer Risk of Lung...Model appears to work equally well on diagnostic and low-dose screening CT An AI tool helps doctors predict the cancer risk in lung nodules...

May 26, 2022 / Events
Optellum team amongst innovators attending the American Association for Thoracic Surgery...Back in person for the first time since 2019, the Optellum team reunited with surgeons and thought leaders attending the 102nd Annual Meeting of...

May 23, 2022 / Events
Optellum science features in posters at the American Thoracic Society annual...The Optellum team attended the American Thoracic Society (ATS) international conference in San Francisco, meeting existing partners and friends and making new connections with...

Optellum presents new discoveries in AI and Machine Learning
Members of the Optellum team recently attended our first Oxford innovation event since the pandemic, where we enjoyed meeting and connecting with academics, industry...

March 31, 2022 / Clinical & Regulatory, News & Press
PRESS RELEASE: Optellum attains CE marking for its early lung cancer...Optellum Virtual Nodule Clinic, including its proprietary artificial intelligence lung cancer prediction solution, has achieved CE certification under the European Union’s Medical Device Regulation....

March 21, 2022 / Customer stories, Research & Publications
Oxford study on Optellum software published in European RadiologyResearchers from the University of Oxford and Oxford University Hospitals NHS Foundation Trust (OUH) have published the results of an academic study in European...

February 22, 2022 / Clinical & Regulatory, Partnerships
Optellum recognised by the NHS and Health Education England and included...Optellum is referenced within the report with recommendations on how AI will be implemented and physicians trained in new technologies across the NHS Optellum...

January 4, 2022 / Customer stories, Partnerships
Vanderbilt Lung Institute implements the Optellum Virtual Lung Nodule ClinicVanderbilt University Hospital Medical Center (VUMC) is the first hospital in Tennessee to introduce Optellum's Virtual Nodule Clinic. The world-leading hospital was one of...

November 26, 2021 / News & Press, Partnerships
PRESS RELEASE: GE Healthcare and Optellum Join Forces to Advance Lung...Oxford, UK/Chalfont St Giles 26 November 2021 13:00 GMT - GE Healthcare and Optellum today announced that they have signed a letter of intent...

September 14, 2021 / Team & Culture
PRESS RELEASE: Optellum Appoints Jason Pesterfield as CEO to Drive Commercial...Fast-growing lung-health AI startup strengthens executive team with business leader experienced in medical devices for lung cancer diagnosis. Jason Pesterfield was previously CEO at...

August 18, 2021 / Insights, Partnerships
Optellum and J&J announce collaboration on lung cancer treatmentLatest news, insights, opinion and analysis on the Medtech industry from Medtech Innovation News. Med-Tech Innovation is the leading multi-platform communication brand for the...

August 18, 2021 / Insights, Partnerships
Optellum and J&J to Use AI to Transform Lung Cancer TreatmentHealthTech HotSpot is an independent new media platform dedicated to the advancement of technological innovations that help transform healthcare. A curated and indexed forum...

August 18, 2021 / Insights, Partnerships
Optellum announces strategic collaboration with the Lung Cancer initiative at Johnson...Just Entrepreneurs are dedicated to finding interesting ways to champion and support entrepreneurs across all industries. They are interviews, articles, news and more with...

August 18, 2021 / Insights, Partnerships
Lung health startup partners with Johnson & Johnson’s lung cancer initiativeHealth Tech World is for everyone with a professional interest in health technology. It unites academics, researchers, governments and businesses of all sizes around...

August 18, 2021 / Insights, Partnerships
Lung health startup partners with Johnson & Johnson’s lung cancer initiativeThe Clinical Services Journal is the must-read publication for healthcare professionals in across the sector.Clinical Services Journal

August 18, 2021 / Insights, Partnerships
Optellum Collaborates with the Lung Cancer Initiative at J&JApplied Radiation Oncology is published quarterly (March, June, September, December) and aims to provide a practical overview of the issues facing radiation oncologists and...

August 18, 2021 / Insights
Digital Health Roundup (subscription required)Fortune Reporter: Sy Mukherjee

August 18, 2021 / News & Press, Partnerships
PRESS RELEASE: Optellum Announces Strategic collaboration with the Lung Cancer Initiative...Rapidly growing lung health startup aims to redefine early interception of lung cancer using artificial intelligence (AI) decision support software. OXFORD, UK / HOUSTON,...
Redefining early intervention of lung disease
starting with one of the deadliest, lung cancer
Book your demo
Optellum is trusted by industry & academic leaders




































Certification





Redefining early intervention of lung disease
starting with one of the deadliest, lung cancer
Contact us